{"recordsFiltered":48703,"recordsTotal":48703,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-completion_date&start=48000","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-completion_date&start=47400","results":[{"registry_id":"NCT03821857","publication_url":"https://clinicaltrials.gov/study/NCT03821857","title":"Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease","has_exemption":false,"start_date":"2019-06-27","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03972202","publication_url":"https://clinicaltrials.gov/study/NCT03972202","title":"The Role of Cerebellum in Speech","has_exemption":false,"start_date":"2019-09-15","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05951179","publication_url":"https://clinicaltrials.gov/study/NCT05951179","title":"A Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of Intravesical Instillation of TARA-002 in Adults With High-Grade Non-Muscle Invasive Bladder Cancer","has_exemption":false,"start_date":"2023-09-15","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Protara Therapeutics","sponsor_slug":"protara-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06205836","publication_url":"https://clinicaltrials.gov/study/NCT06205836","title":"Evaluating a Surgical-Sparing Approach Using Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer","has_exemption":false,"start_date":"2024-06-13","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06851338","publication_url":"https://clinicaltrials.gov/study/NCT06851338","title":"Pediatric Down Syndrome Post-Approval Study","has_exemption":false,"start_date":"2025-02-28","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Inspire Medical Systems, Inc.","sponsor_slug":"inspire-medical-systems-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07010692","publication_url":"https://clinicaltrials.gov/study/NCT07010692","title":"Using Fractional Lasers and Tirbanibulin Ointment to Treat Keratinocyte Carcinomas","has_exemption":false,"start_date":"2025-05-16","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Bruce Robinson, MD","sponsor_slug":"bruce-robinson-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06876662","publication_url":"https://clinicaltrials.gov/study/NCT06876662","title":"Long-Term Safety of Pirtobrutinib in Participants From Study LOXO-BTK-18001 With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma","has_exemption":false,"start_date":"2025-05-20","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06876649","publication_url":"https://clinicaltrials.gov/study/NCT06876649","title":"A Master Protocol to Evaluate the Long-Term Safety of Pirtobrutinib","has_exemption":false,"start_date":"2025-05-20","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06961955","publication_url":"https://clinicaltrials.gov/study/NCT06961955","title":"FAST NOVEMBER: A Phase II Randomized Trial of a 5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer","has_exemption":false,"start_date":"2025-05-21","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07162181","publication_url":"https://clinicaltrials.gov/study/NCT07162181","title":"Long-Term Safety of Pirtobrutinib in Participants From Study J2N-MC-JZNJ With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma","has_exemption":false,"start_date":"2025-08-07","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06814496","publication_url":"https://clinicaltrials.gov/study/NCT06814496","title":"RAdiation comBined With BIspecific T-Cell Engager in DLL3 Expressing Tumors (RABBIT) Study: A Phase I/II Study of AMG757 / Tarlatamab and Concurrent Radiation Therapy in Tumors With High Prevalence of DLL3","has_exemption":false,"start_date":"2025-09-08","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Arizona","sponsor_slug":"university-of-arizona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07186842","publication_url":"https://clinicaltrials.gov/study/NCT07186842","title":"First-in-human, Open-label, Multi-site, Phase I/IIa, Dose Escalation Trial With Expansion Cohorts to Evaluate Safety and Preliminary Efficacy of BNT329 in Participants With Advanced Solid Tumors Known to Express CA19-9","has_exemption":false,"start_date":"2025-11-18","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Biontech SE","sponsor_slug":"biontech-se","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07097363","publication_url":"https://clinicaltrials.gov/study/NCT07097363","title":"A Pilot Study of Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for Upfront Treatment of Aggressive B-Cell Non-Hodgkin Lymphomas","has_exemption":false,"start_date":"2025-12-07","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224438","publication_url":"https://clinicaltrials.gov/study/NCT07224438","title":"Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea","has_exemption":false,"start_date":"2025-12-09","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Stephanie B. Seminara, MD","sponsor_slug":"stephanie-b-seminara-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07218341","publication_url":"https://clinicaltrials.gov/study/NCT07218341","title":"Long-Term Safety of Pirtobrutinib in Participants From Study LOXO-BTK-20020 With BTKi Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma","has_exemption":false,"start_date":"2026-03-09","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06410001","publication_url":"https://clinicaltrials.gov/study/NCT06410001","title":"CE-STAND: Cervical Epidural STimulation After Neurologic Damage","has_exemption":false,"start_date":"2026-03-15","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07526740","publication_url":"https://clinicaltrials.gov/study/NCT07526740","title":"Combining Brain Stimulation With Computerized Cognitive Training for MCI","has_exemption":false,"start_date":"2026-03-16","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07298421","publication_url":"https://clinicaltrials.gov/study/NCT07298421","title":"A Phase III Randomized Double-Blind Multi-Center Treat-Through Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Children Aged 2-17 Years With Moderately to Severely Active Crohn's Disease","has_exemption":false,"start_date":"2026-05-29","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07206849","publication_url":"https://clinicaltrials.gov/study/NCT07206849","title":"A Phase 2 Study of Tovorafenib in Pediatric and Young Adult Patients Newly Diagnosed With High-Grade Glioma (HGG), Including Diffuse Intrinsic Pontine Glioma (DIPG), Which Harbor Alterations in the Mitogen-Activated Protein Kinase (MAPK) Pathway","has_exemption":false,"start_date":"2026-05-31","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Nationwide Children's Hospital","sponsor_slug":"nationwide-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07467707","publication_url":"https://clinicaltrials.gov/study/NCT07467707","title":"A Phase 3b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of an Adjuvanted Chikungunya Virus Virus-like Particle (CHIKV VLP) Vaccine for the Prevention of Chikungunya Disease in Adolescents (12 to <18 Years) and Adults (≥18 Years)","has_exemption":false,"start_date":"2026-05-31","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Bavarian Nordic","sponsor_slug":"bavarian-nordic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07340554","publication_url":"https://clinicaltrials.gov/study/NCT07340554","title":"Neuroimaging of Instrumental Learning Networks in Adolescent Cannabis Use Treatment","has_exemption":false,"start_date":"2026-06-30","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07087938","publication_url":"https://clinicaltrials.gov/study/NCT07087938","title":"Safety and Behavioral Pharmacology of Cannabichromene as an Adjunct to Rheumatoid Arthritis Treatment; Effects on Inflammatory Markers and Rheumatoid Arthritis Disease Activity","has_exemption":false,"start_date":"2028-07-15","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Crystal Lederhos Smith","sponsor_slug":"crystal-lederhos-smith","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04900623","publication_url":"https://clinicaltrials.gov/study/NCT04900623","title":"Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study","has_exemption":false,"start_date":"2021-07-02","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"Jonathan Schoenfeld, MD, MPH","sponsor_slug":"jonathan-schoenfeld-md-mph","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07060066","publication_url":"https://clinicaltrials.gov/study/NCT07060066","title":"Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia","has_exemption":false,"start_date":"2024-05-21","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06872333","publication_url":"https://clinicaltrials.gov/study/NCT06872333","title":"Allogeneic Hematopoietic Stem Cell Transplant for Patients With High Risk Hemoglobinopathies and Other Red Cell Transfusion Dependent Disorders","has_exemption":false,"start_date":"2024-11-19","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06810778","publication_url":"https://clinicaltrials.gov/study/NCT06810778","title":"Phase I/II Study of Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)","has_exemption":false,"start_date":"2025-05-02","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06996730","publication_url":"https://clinicaltrials.gov/study/NCT06996730","title":"A Double-Blind, Placebo-Controlled, Double-Dummy Study of Donanemab and RG6289 in PSEN1 E280A Mutation Carriers, and in Non-Randomized, Placebo-Treated Non-Carriers From the Same Kindred, to Evaluate the Efficacy and Safety of Donanemab, RG6289, or the Combination of Donanemab and RG6289, in the Treatment of Autosomal-Dominant Alzheimer's Disease","has_exemption":false,"start_date":"2026-01-15","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"Banner Health","sponsor_slug":"banner-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07142551","publication_url":"https://clinicaltrials.gov/study/NCT07142551","title":"Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response Via Modulation of ANdrogen Receptor (the SPIDERMAN Trial)","has_exemption":false,"start_date":"2026-03-09","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06800092","publication_url":"https://clinicaltrials.gov/study/NCT06800092","title":"Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment","has_exemption":false,"start_date":"2026-03-15","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Medical Branch, Galveston","sponsor_slug":"the-university-of-texas-medical-branch-galveston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07546942","publication_url":"https://clinicaltrials.gov/study/NCT07546942","title":"Autism Spectral Disorder (ASD) In Adolescent-Adults Treated by Multimodal Protocol: IV Autologous cSVF, Interval IV Autologous MSCs (Cryopreserved), Strick Ketogenic Diet RESET Program, and Fecal Microbiota Transplantation (FMT)","has_exemption":false,"start_date":"2026-04-30","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"Black Tie Medical, Inc.","sponsor_slug":"black-tie-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07566039","publication_url":"https://clinicaltrials.gov/study/NCT07566039","title":"Prospective Cohort Study of Athletes Following an Injection of Platelet-Poor Plasma Into an Acute Muscle Injury","has_exemption":false,"start_date":"2026-05-01","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04457076","publication_url":"https://clinicaltrials.gov/study/NCT04457076","title":"A Phase 3, Prospective, Multi-Center, Single-Arm, Open-Label Study to Evaluate LevoCept™, a Long-Acting Reversible Intrauterine System for Contraceptive Efficacy, Safety, and Tolerability","has_exemption":false,"start_date":"2026-06-01","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"Sebela Women's Health Inc.","sponsor_slug":"sebela-womens-health-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07420218","publication_url":"https://clinicaltrials.gov/study/NCT07420218","title":"Impact of FSH and Estradiol on Sympathetic Function in Menopausal Women","has_exemption":false,"start_date":"2026-09-01","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Delaware","sponsor_slug":"university-of-delaware","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07019454","publication_url":"https://clinicaltrials.gov/study/NCT07019454","title":"Baystate Health Physician Sponsored - Investigational Device Exception: Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysms","has_exemption":false,"start_date":"2025-06-03","completion_date":"2030-06-03","has_results":false,"results_due":false,"sponsor_name":"Baystate Medical Center","sponsor_slug":"baystate-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07215585","publication_url":"https://clinicaltrials.gov/study/NCT07215585","title":"A Phase III, Multicentre, Open-Label, Randomised Study Evaluating the Efficacy and Safety of R-mini-CHOP x2 Followed by AZD0486 Versus R-mini-CHOP x6 in Elderly or Unfit Participants With Newly Diagnosed Large B-cell Lymphoma (SOUNDTRACK-D2)","has_exemption":false,"start_date":"2025-11-11","completion_date":"2030-06-10","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05163288","publication_url":"https://clinicaltrials.gov/study/NCT05163288","title":"Effects of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C (NPC): A Phase III, Randomized, Placebo-controlled, Double-blind, Crossover Study","has_exemption":false,"start_date":"2022-06-30","completion_date":"2030-06-12","has_results":false,"results_due":false,"sponsor_name":"IntraBio Inc","sponsor_slug":"intrabio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07226999","publication_url":"https://clinicaltrials.gov/study/NCT07226999","title":"A GLOBAL PHASE 2/3 INTERVENTIONAL STUDY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY IN PARTICIPANTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER","has_exemption":false,"start_date":"2025-12-09","completion_date":"2030-06-14","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04452591","publication_url":"https://clinicaltrials.gov/study/NCT04452591","title":"A Phase 3 Study of Cretostimogene Grenadenorepvec in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus-Calmette-Guerin (BCG)","has_exemption":false,"start_date":"2020-10-27","completion_date":"2030-06-16","has_results":false,"results_due":false,"sponsor_name":"CG Oncology, Inc.","sponsor_slug":"cg-oncology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05170204","publication_url":"https://clinicaltrials.gov/study/NCT05170204","title":"A Phase I-III, Multicenter Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Patients Selected According to Biomarker Status, With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2022-11-01","completion_date":"2030-06-16","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05987449","publication_url":"https://clinicaltrials.gov/study/NCT05987449","title":"A Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A","has_exemption":false,"start_date":"2023-09-21","completion_date":"2030-06-16","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07116616","publication_url":"https://clinicaltrials.gov/study/NCT07116616","title":"A Phase 1/2, Open-label, Multicenter Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2025-09-30","completion_date":"2030-06-17","has_results":false,"results_due":false,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07154290","publication_url":"https://clinicaltrials.gov/study/NCT07154290","title":"A Phase 2 Study to Investigate Ubamatamab With and Without REGN7075 in Treatment-Experienced Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2026-03-18","completion_date":"2030-06-24","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06077760","publication_url":"https://clinicaltrials.gov/study/NCT06077760","title":"A Phase 3, Randomized, Double-blind, Placebo- and Active-Comparator-Controlled Clinical Study of Adjuvant V940 (mRNA-4157) Plus Pembrolizumab Versus Adjuvant Placebo Plus Pembrolizumab in Participants With Resected Stage II, IIIA, IIIB (N2) Non-small Cell Lung Cancer (INTerpath-002)","has_exemption":false,"start_date":"2023-12-06","completion_date":"2030-06-25","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06578247","publication_url":"https://clinicaltrials.gov/study/NCT06578247","title":"A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial Of Quizartinib Administered in Combination With Induction and Consolidation Chemotherapy and Administered as Maintenance Therapy in Adult Patients With Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia","has_exemption":false,"start_date":"2024-11-19","completion_date":"2030-06-26","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07029828","publication_url":"https://clinicaltrials.gov/study/NCT07029828","title":"A LONG-TERM, DOUBLE-BLIND EXTENSION STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF RITLECITINIB IN PARTICIPANTS WITH SEVERE ALOPECIA AREATA WHO PREVIOUSLY COMPLETED STUDIES B7981027 OR B7981031","has_exemption":false,"start_date":"2025-09-10","completion_date":"2030-06-26","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04004169","publication_url":"https://clinicaltrials.gov/study/NCT04004169","title":"Closed-Loop Deep Brain Stimulation for Treatment-Resistant Depression","has_exemption":false,"start_date":"2019-07-18","completion_date":"2030-06-28","has_results":false,"results_due":false,"sponsor_name":"Andrew Krystal","sponsor_slug":"andrew-krystal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05161195","publication_url":"https://clinicaltrials.gov/study/NCT05161195","title":"A Post-trial Access Roll-over Study to Allow Access to Ribociclib (LEE011) for Patients Who Are on Ribociclib Treatment in Novartis-sponsored Study","has_exemption":false,"start_date":"2022-07-07","completion_date":"2030-06-28","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05562830","publication_url":"https://clinicaltrials.gov/study/NCT05562830","title":"A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Study of Investigational Agents With or Without Pembrolizumab in Participants With PD-1/L1 Refractory Locally Advanced or Metastatic Urothelial Carcinoma (KEYMAKER-U04): Substudy 04A","has_exemption":false,"start_date":"2022-11-16","completion_date":"2030-06-28","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07127913","publication_url":"https://clinicaltrials.gov/study/NCT07127913","title":"Closed-Loop Deep Brain Stimulation for Bipolar Depression (PReSiDio-BP)","has_exemption":false,"start_date":"2025-07-16","completion_date":"2030-06-28","has_results":false,"results_due":false,"sponsor_name":"Andrew Krystal","sponsor_slug":"andrew-krystal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06994845","publication_url":"https://clinicaltrials.gov/study/NCT06994845","title":"A Single-arm, Multicenter, Phase III Study to Assess Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients of 2 to <18 Years of Age With Primary Immunoglobulin A Nephropathy (IgAN)","has_exemption":false,"start_date":"2025-11-27","completion_date":"2030-06-28","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06966362","publication_url":"https://clinicaltrials.gov/study/NCT06966362","title":"Varenicline for Smoking Reduction in Veterans Unwilling to Quit","has_exemption":false,"start_date":"2026-07-01","completion_date":"2030-06-28","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03971669","publication_url":"https://clinicaltrials.gov/study/NCT03971669","title":"Collection of Blood Samples for In-Vitro Studies From Healthy Adult Blood Donors Who Have Received Oral Typhoid Vaccine (TY21A)","has_exemption":false,"start_date":"2004-01-16","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01630850","publication_url":"https://clinicaltrials.gov/study/NCT01630850","title":"Islet Transplantation in Patients With \"Brittle\" Type I Diabetes","has_exemption":false,"start_date":"2012-05-31","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04305145","publication_url":"https://clinicaltrials.gov/study/NCT04305145","title":"Phase II Study of Infliximab for the Treatment of Immune Checkpoint Inhibitor Colitis","has_exemption":false,"start_date":"2020-08-31","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04639050","publication_url":"https://clinicaltrials.gov/study/NCT04639050","title":"A Phase Ib/IIa, Randomized, Double Blind, Placebo-Controlled, Multiple Ascending Dose, Parallel-Group Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Patients With Prodromal or Mild to Moderate Alzheimer's Disease","has_exemption":false,"start_date":"2021-03-15","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05422222","publication_url":"https://clinicaltrials.gov/study/NCT05422222","title":"A Phase 3 Study Evaluating the Pharmacokinetics, Safety, and Tolerability of VX-121/Tezacaftor/Deutivacaftor Triple Combination Therapy in Cystic Fibrosis Subjects 1 Through 11 Years of Age","has_exemption":false,"start_date":"2022-06-21","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05633615","publication_url":"https://clinicaltrials.gov/study/NCT05633615","title":"A Randomized Phase II Trial of Consolidation Therapy Following CD19 CAR T-Cell Treatment for Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Grade IIIB Follicular Lymphoma","has_exemption":false,"start_date":"2023-06-12","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06118892","publication_url":"https://clinicaltrials.gov/study/NCT06118892","title":"Post-Market Evaluation of the MISHA® Knee System for Symptom Relief in Subjects With Medial Knee Osteoarthritis","has_exemption":false,"start_date":"2023-11-03","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Moximed","sponsor_slug":"moximed","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06384573","publication_url":"https://clinicaltrials.gov/study/NCT06384573","title":"The Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Amyloid Removal Trial (ART): A Phase IIIb/IV Open-Label Study of Lecanemab to Evaluate Prevention and Progression of Dominantly Inherited Alzheimer's Disease","has_exemption":false,"start_date":"2024-06-10","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06904313","publication_url":"https://clinicaltrials.gov/study/NCT06904313","title":"Evaluation of Ultralow Dose PET Imaging for Detecting PSMA Expression","has_exemption":false,"start_date":"2025-05-12","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Akiva Mintz","sponsor_slug":"akiva-mintz","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06956391","publication_url":"https://clinicaltrials.gov/study/NCT06956391","title":"Evaluation of Ultralow Dose PET Imaging for Detecting 18F-FDG Uptake","has_exemption":false,"start_date":"2025-05-12","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Akiva Mintz","sponsor_slug":"akiva-mintz","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07542158","publication_url":"https://clinicaltrials.gov/study/NCT07542158","title":"Evaluation of Ultralow Dose PET Imaging for Detecting 18F-FDOPA Uptake","has_exemption":false,"start_date":"2025-05-12","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Akiva Mintz","sponsor_slug":"akiva-mintz","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07012993","publication_url":"https://clinicaltrials.gov/study/NCT07012993","title":"Evaluation of Ultralow Dose PET Imaging for Detecting Amyloid Tracer Uptake","has_exemption":false,"start_date":"2025-05-20","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Akiva Mintz","sponsor_slug":"akiva-mintz","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07038343","publication_url":"https://clinicaltrials.gov/study/NCT07038343","title":"A Phase 1/2, First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2025-06-04","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Avenzo Therapeutics, Inc.","sponsor_slug":"avenzo-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06464926","publication_url":"https://clinicaltrials.gov/study/NCT06464926","title":"A Prospective Randomized Controlled Trial of Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System","has_exemption":false,"start_date":"2025-06-23","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Enterra Medical, Inc.","sponsor_slug":"enterra-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06953089","publication_url":"https://clinicaltrials.gov/study/NCT06953089","title":"A Phase II, Multicenter, Open-Label Trial of DB-1311 in Combination With BNT327 or DB-1305 in Participants With Advanced/Metastatic Solid Tumors","has_exemption":false,"start_date":"2025-07-18","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"DualityBio Inc.","sponsor_slug":"dualitybio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07284563","publication_url":"https://clinicaltrials.gov/study/NCT07284563","title":"Evaluation of Ultralow Dose PET Imaging for Detecting 18F-NaF Uptake","has_exemption":false,"start_date":"2025-09-01","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Akiva Mintz","sponsor_slug":"akiva-mintz","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06726161","publication_url":"https://clinicaltrials.gov/study/NCT06726161","title":"Phase 1/2 Randomized, Controlled, Open-label Trial of Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ Unresectable Hepatocellular Carcinoma (HCC)","has_exemption":false,"start_date":"2025-09-05","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"RayzeBio, Inc.","sponsor_slug":"rayzebio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07212686","publication_url":"https://clinicaltrials.gov/study/NCT07212686","title":"An Open-Label, Single-Center Study of Synthetic Angiotensin II/Giapreza in Pediatric Patients With Refractory Hypotension Despite Receiving Fluid Therapy and Vasoactive Therapy","has_exemption":false,"start_date":"2025-09-09","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Todd Sweberg","sponsor_slug":"todd-sweberg","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06520098","publication_url":"https://clinicaltrials.gov/study/NCT06520098","title":"Benefit of Venetoclax Addition (\"Benefit VA\") in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)","has_exemption":false,"start_date":"2025-10-01","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07284576","publication_url":"https://clinicaltrials.gov/study/NCT07284576","title":"Evaluation of 0.25mCi PET Imaging for Detecting Cardiac Perfusion","has_exemption":false,"start_date":"2025-12-16","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Akiva Mintz","sponsor_slug":"akiva-mintz","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07067463","publication_url":"https://clinicaltrials.gov/study/NCT07067463","title":"A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing Orelabrutinib to Placebo in Patients With Primary Progressive Multiple Sclerosis","has_exemption":false,"start_date":"2025-12-31","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Zenas BioPharma (USA), LLC","sponsor_slug":"zenas-biopharma-usa-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07214649","publication_url":"https://clinicaltrials.gov/study/NCT07214649","title":"A Prospective Study Using Patient-Derived Extrahepatic Cholangiocyte Organoids for Refractory Bile Leaks","has_exemption":false,"start_date":"2026-01-31","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","sponsor_slug":"fondazione-policlinico-universitario-agostino-gemelli-irccs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07084441","publication_url":"https://clinicaltrials.gov/study/NCT07084441","title":"Comparison of Outcomes of Management of Bowel Obstruction","has_exemption":false,"start_date":"2026-02-28","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07223814","publication_url":"https://clinicaltrials.gov/study/NCT07223814","title":"Bleximenib or Placebo in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for the Treatment of Patients With Newly Diagnosed KMT2A-rearranged or NPM1-mutant Acute Myeloid Leukemia Eligible for Intensive Chemotherapy: a Double-blind Phase 3 Study","has_exemption":false,"start_date":"2026-03-01","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Stichting Hemato-Oncologie voor Volwassenen Nederland","sponsor_slug":"stichting-hemato-oncologie-voor-volwassenen-nederland","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07436793","publication_url":"https://clinicaltrials.gov/study/NCT07436793","title":"Evaluating Promising Progestins in Endometrial Cancer Through a Rotating Umbrella Surgical Window Trial - The PRO-WINDOW TRIAL for Endometrial Cancer","has_exemption":false,"start_date":"2026-03-01","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"New Mexico Cancer Research Alliance","sponsor_slug":"new-mexico-cancer-research-alliance","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06474273","publication_url":"https://clinicaltrials.gov/study/NCT06474273","title":"A Multicenter Randomized Controlled Trial to Treat Acute t Cell Mediated Rejection in Kidney and Kidney-pancreas Transplant Recipients","has_exemption":false,"start_date":"2026-03-13","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Sydney","sponsor_slug":"university-of-sydney","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07299019","publication_url":"https://clinicaltrials.gov/study/NCT07299019","title":"A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing Orelabrutinib to Placebo in Patients With Non-active Secondary Progressive Multiple Sclerosis","has_exemption":false,"start_date":"2026-03-23","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Zenas BioPharma (USA), LLC","sponsor_slug":"zenas-biopharma-usa-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07415044","publication_url":"https://clinicaltrials.gov/study/NCT07415044","title":"A Randomized, Multicenter, Double-Blind, Placebo-Controlled Development Program to Evaluate the Efficacy and Safety of LY4268989 (MORF-057) for the Treatment of Adults With Moderately to Severely Active Ulcerative Colitis (EMERALD-3)","has_exemption":false,"start_date":"2026-03-26","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07428499","publication_url":"https://clinicaltrials.gov/study/NCT07428499","title":"A Phase 3 Extension Study of siRNA Targeting of Prekallikrein With ADX-324 in Participants With Hereditary Angioedema","has_exemption":false,"start_date":"2026-04-02","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"ADARx Pharmaceuticals, Inc.","sponsor_slug":"adarx-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07135596","publication_url":"https://clinicaltrials.gov/study/NCT07135596","title":"Research on the Effectiveness and Safety of Treatment With OviTex® PRS - a Breast Reconstruction Evaluation","has_exemption":false,"start_date":"2026-04-10","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Tela Bio Inc","sponsor_slug":"tela-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07566052","publication_url":"https://clinicaltrials.gov/study/NCT07566052","title":"A Randomized, Open-label, Phase 3 Study of Setidegrasib (ASP3082) Versus Docetaxel in Participants With KRAS G12D-mutated Locally Advanced (Unresectable) or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on or After Platinum Based Chemotherapy and Checkpoint Inhibitor Therapy (CPI)","has_exemption":false,"start_date":"2026-04-30","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07398508","publication_url":"https://clinicaltrials.gov/study/NCT07398508","title":"Phase I/II Study of NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes Disease: Double-blind Placebo-controlled Randomized Crossover Clinical Trial.","has_exemption":false,"start_date":"2026-06-01","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Stephen G. Kaler","sponsor_slug":"stephen-g-kaler","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07032701","publication_url":"https://clinicaltrials.gov/study/NCT07032701","title":"Assessing the Impact of a Disposable Negative Pressure Wound Therapy Device on Surgical Wounds of the Lower Extremities Following Mohs Micrographic Surgery","has_exemption":false,"start_date":"2026-06-30","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07570940","publication_url":"https://clinicaltrials.gov/study/NCT07570940","title":"Effectiveness Of Liposomal Bupivacaine Stellate Ganglion Blockade In Preventing Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting Surgery: A Randomized Placebo-Controlled Trial","has_exemption":false,"start_date":"2026-06-30","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07167940","publication_url":"https://clinicaltrials.gov/study/NCT07167940","title":"RAPID5: Rapid Acceleration Process for Intensive Treatment of PTSD in 5 Days","has_exemption":false,"start_date":"2026-07-01","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07265830","publication_url":"https://clinicaltrials.gov/study/NCT07265830","title":"The Building Adaptive School-based Interventions for Caries Study (BASICS): A Phase III Sequential, Multiple-Assignment, Randomized Trial of Minimally Invasive Therapies to Reduce Treatment Nonresponse","has_exemption":false,"start_date":"2026-09-30","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07210606","publication_url":"https://clinicaltrials.gov/study/NCT07210606","title":"Central Apnea in Heart Failure: Physiological Mechanisms to Inform Treatment","has_exemption":false,"start_date":"2026-10-01","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07288463","publication_url":"https://clinicaltrials.gov/study/NCT07288463","title":"Hearing Loss and Genetic Risks for Dementia","has_exemption":false,"start_date":"2027-07-01","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04814082","publication_url":"https://clinicaltrials.gov/study/NCT04814082","title":"Prospective Functional, Gait, and Outcome Comparison Study of Medial Pivot","has_exemption":false,"start_date":"2021-02-01","completion_date":"2030-07-01","has_results":false,"results_due":false,"sponsor_name":"LifeBridge Health","sponsor_slug":"lifebridge-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05564377","publication_url":"https://clinicaltrials.gov/study/NCT05564377","title":"Molecular Analysis for Combination Therapy Choice (ComboMATCH)","has_exemption":false,"start_date":"2023-04-07","completion_date":"2030-07-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07121595","publication_url":"https://clinicaltrials.gov/study/NCT07121595","title":"PRECEDENT: Pilot Phase II Study of Personalized Radiation to the Contralateral Neck Directed by Sentinel Node Evaluation in Lateralized Oral Cavity Squamous Cell Carcinoma","has_exemption":false,"start_date":"2025-07-17","completion_date":"2030-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Michigan Rogel Cancer Center","sponsor_slug":"university-of-michigan-rogel-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07456033","publication_url":"https://clinicaltrials.gov/study/NCT07456033","title":"The MODIFY Study: A Phase 3b/4 Randomized, Double-blind, Placebo-controlled, Multi-centre Study Evaluating the Impact of Early Intervention With Depemokimab on Exacerbation Rate, Clinical Remission, Lung Function Decline, and Safety in Adults and Adolescents With at Risk Type 2 Asthma, Conducted up to 156 Weeks","has_exemption":false,"start_date":"2026-03-06","completion_date":"2030-07-01","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06077071","publication_url":"https://clinicaltrials.gov/study/NCT06077071","title":"MRIdian \"RADAR\" Trial - Radiosurgical Debulking of Asymptomatic/Radiographic Spinal Cord Compression Using Stereotactic MRI-guided Adaptive Radiotherapy","has_exemption":false,"start_date":"2026-07-01","completion_date":"2030-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06525389","publication_url":"https://clinicaltrials.gov/study/NCT06525389","title":"Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST)","has_exemption":false,"start_date":"2026-07-01","completion_date":"2030-07-01","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07418398","publication_url":"https://clinicaltrials.gov/study/NCT07418398","title":"Exoskeletal-assisted Walking Combined With Transcutaneous Spinal Cord Stimulation: Effect on Imaging and Serum Biomarkers of Skeletal Muscle Mass and Bone Strength","has_exemption":false,"start_date":"2026-07-01","completion_date":"2030-07-01","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07464028","publication_url":"https://clinicaltrials.gov/study/NCT07464028","title":"Assessing Target Engagement for Terazosin in Parkinson's Disease (TZPD2)","has_exemption":false,"start_date":"2026-07-01","completion_date":"2030-07-01","has_results":false,"results_due":false,"sponsor_name":"Nandakumar Narayanan","sponsor_slug":"nandakumar-narayanan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04715646","publication_url":"https://clinicaltrials.gov/study/NCT04715646","title":"Open-Label, Single-Arm, Multicenter Study to Evaluate Long-Term Safety and Tolerability of Brivaracetam Used as Adjunctive Treatment in Pediatric Study Participants With Epilepsy","has_exemption":false,"start_date":"2021-03-11","completion_date":"2030-07-08","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04684602","publication_url":"https://clinicaltrials.gov/study/NCT04684602","title":"Evaluation of the Safety, Tolerability and Efficacy of Regenerative Therapy for the Treatment of Various Chronic and Acute Conditions","has_exemption":false,"start_date":"2020-07-09","completion_date":"2030-07-09","has_results":false,"results_due":false,"sponsor_name":"Thomas Advanced Medical LLC","sponsor_slug":"thomas-advanced-medical-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07146906","publication_url":"https://clinicaltrials.gov/study/NCT07146906","title":"An Open-label, Multicenter Study to Assess the Effect of Zigakibart Treatment on Histologic, Circulating, and Excreted Markers of Kidney Disease and Dysfunction in Adult Patients With IgA Nephropathy.","has_exemption":false,"start_date":"2026-03-26","completion_date":"2030-07-12","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07089901","publication_url":"https://clinicaltrials.gov/study/NCT07089901","title":"Project DEDUCE: Digital Envirotyping to Develop Understanding of Cigarette Smoking and the Environment","has_exemption":false,"start_date":"2026-05-01","completion_date":"2030-07-14","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06054230","publication_url":"https://clinicaltrials.gov/study/NCT06054230","title":"Genomic Sequencing for Evaluation of Fetal Structural Anomalies","has_exemption":false,"start_date":"2023-09-18","completion_date":"2030-07-15","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06678737","publication_url":"https://clinicaltrials.gov/study/NCT06678737","title":"CBIT+TMS R33 Phase","has_exemption":false,"start_date":"2025-02-27","completion_date":"2030-07-15","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07002216","publication_url":"https://clinicaltrials.gov/study/NCT07002216","title":"A Phase 2 Trial of Abbreviated Brentuximab Vedotin, Etoposide, Cyclophosphamide, Adriamycin, Dacarbazine, and Dexamethasone (BrECADD) Therapy in Stage 2 B-IV Hodgkin Lymphoma","has_exemption":false,"start_date":"2025-07-15","completion_date":"2030-07-15","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220720","publication_url":"https://clinicaltrials.gov/study/NCT07220720","title":"Inclusion of POSLUMA® ((18)F-rhPSMA-7.3) PET-CT Imaging Improves Diagnostic Accuracy of Clinically-Significant Prostate Cancer Diagnosis in Men With PIRADS 2 and 3 Lesions on MRI","has_exemption":false,"start_date":"2025-11-04","completion_date":"2030-07-15","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06711887","publication_url":"https://clinicaltrials.gov/study/NCT06711887","title":"An Open-label Extension Study to Assess the Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Adult Participants With Lupus Nephritis Who Have Completed Study Treatment in the CVAY736K12301 Core Study (SIRIUS-LN Extension)","has_exemption":false,"start_date":"2025-05-19","completion_date":"2030-07-16","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02543983","publication_url":"https://clinicaltrials.gov/study/NCT02543983","title":"The Neurobiology of Suicide","has_exemption":false,"start_date":"2015-12-01","completion_date":"2030-07-21","has_results":false,"results_due":false,"sponsor_name":"National Institute of Mental Health (NIMH)","sponsor_slug":"national-institute-of-mental-health-nimh","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05442216","publication_url":"https://clinicaltrials.gov/study/NCT05442216","title":"Phase II Study of TAGraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Previous Exposure to HypOmethylatiNG Agents","has_exemption":false,"start_date":"2024-05-01","completion_date":"2030-07-21","has_results":false,"results_due":false,"sponsor_name":"Joshua Zeidner","sponsor_slug":"joshua-zeidner","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07286266","publication_url":"https://clinicaltrials.gov/study/NCT07286266","title":"A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer","has_exemption":false,"start_date":"2026-06-24","completion_date":"2030-07-22","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06022939","publication_url":"https://clinicaltrials.gov/study/NCT06022939","title":"A Phase III, Randomized Study of Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone (Dara-VCD) Induction Followed by Autologous Stem Cell Transplant or Dara-VCD Consolidation and Daratumumab Maintenance in Patients With Newly Diagnosed AL Amyloidosis","has_exemption":false,"start_date":"2024-07-01","completion_date":"2030-07-29","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03961945","publication_url":"https://clinicaltrials.gov/study/NCT03961945","title":"Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma","has_exemption":false,"start_date":"2021-07-01","completion_date":"2030-07-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06561386","publication_url":"https://clinicaltrials.gov/study/NCT06561386","title":"A Phase 3, Randomized, Open-label Study of Nivolumab + Relatlimab Fixed-dose Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy as First-line Treatment for Participants With Non-squamous (NSQ), Stage IV or Recurrent Non-small Cell Lung Cancer and With Tumor Cell PD-L1 Expression ≥ 1%","has_exemption":false,"start_date":"2024-10-07","completion_date":"2030-07-30","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06731413","publication_url":"https://clinicaltrials.gov/study/NCT06731413","title":"Phase 2 Study to Evaluate Reduced Dose Chemotherapy in Combination With Anti-PD-1 Therapy as First Line Treatment in Vulnerable or Older Adults (Vulnerable or Age ≥70) With Advanced PD-L1 TPS <50% Non-small Cell Lung Cancer","has_exemption":false,"start_date":"2025-02-11","completion_date":"2030-07-30","has_results":false,"results_due":false,"sponsor_name":"Virginia Commonwealth University","sponsor_slug":"virginia-commonwealth-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06969755","publication_url":"https://clinicaltrials.gov/study/NCT06969755","title":"Biomarkers to Enhance Early Schizophrenia Treatment","has_exemption":false,"start_date":"2025-09-30","completion_date":"2030-07-30","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07040566","publication_url":"https://clinicaltrials.gov/study/NCT07040566","title":"Investigating Efficacious E-Cigarette Interventions and Cessation Effects on Cancer-Related Biomarkers: A Randomized Trial of Varenicline in Adults","has_exemption":false,"start_date":"2025-10-14","completion_date":"2030-07-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04373785","publication_url":"https://clinicaltrials.gov/study/NCT04373785","title":"A Multi-Center Pilot/Phase I and Phase II Clinical Trial of NG101m Adjuvant Therapy in Newly Diagnosed Glioblastoma Patients","has_exemption":false,"start_date":"2027-01-01","completion_date":"2030-07-30","has_results":false,"results_due":false,"sponsor_name":"NeuGATE Theranostics","sponsor_slug":"neugate-theranostics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06716866","publication_url":"https://clinicaltrials.gov/study/NCT06716866","title":"Temporally Interfering Electric Field Stimulation in the Treatment of Epilepsy - Effect of Temporal Interference on Biomarkers of Epilepsy","has_exemption":false,"start_date":"2019-01-16","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04188535","publication_url":"https://clinicaltrials.gov/study/NCT04188535","title":"RELAY: Repeated Magnetic Resonance Imaging Examinations to Analyze and Assess Your Cancer: A Prospective Study on the Use of Serial Magnetic Resonance Imaging in the Assessment of Changes During Treatment With Radiation Therapy","has_exemption":false,"start_date":"2020-01-15","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04318717","publication_url":"https://clinicaltrials.gov/study/NCT04318717","title":"Adjuvant Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma","has_exemption":true,"start_date":"2020-05-29","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04743141","publication_url":"https://clinicaltrials.gov/study/NCT04743141","title":"Phase 3, Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of Rimegepant for the Acute Treatment of Migraine (With or Without Aura) in Children and Adolescents ≥ 6 to < 18 Years of Age","has_exemption":false,"start_date":"2021-04-28","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05145127","publication_url":"https://clinicaltrials.gov/study/NCT05145127","title":"AN OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF MARSTACIMAB PROPHYLAXIS IN SEVERE (COAGULATION FACTOR ACTIVITY <1%) HEMOPHILIA A PARTICIPANTS WITH OR WITHOUT INHIBITORS OR MODERATELY SEVERE TO SEVERE HEMOPHILIA B PARTICIPANTS (COAGULATION FACTOR ACTIVITY ≤2%) WITH OR WITHOUT INHIBITORS","has_exemption":false,"start_date":"2021-11-17","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05469893","publication_url":"https://clinicaltrials.gov/study/NCT05469893","title":"Immuno-PRISM (PRecision Intervention Smoldering Myeloma): A Randomized Phase II Platform Study of Select Immunotherapies for High-Risk Smoldering Myeloma","has_exemption":false,"start_date":"2022-08-10","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Irene Ghobrial, MD","sponsor_slug":"irene-ghobrial-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05131919","publication_url":"https://clinicaltrials.gov/study/NCT05131919","title":"Pembrolizumab for Locally Advanced, Irresectable, Non-metastatic dMMR Colorectal Cancers. The PUMA Study","has_exemption":false,"start_date":"2022-12-22","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"The Netherlands Cancer Institute","sponsor_slug":"the-netherlands-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05768139","publication_url":"https://clinicaltrials.gov/study/NCT05768139","title":"First-in-Human Study of STX-478, a Mutant-Selective PI3Kα Inhibitor as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors","has_exemption":false,"start_date":"2023-04-17","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06072131","publication_url":"https://clinicaltrials.gov/study/NCT06072131","title":"A Phase 3, Randomized, Open-Label Study Comparing the Efficacy and Safety of the Combination of Beleodaq-CHOP or Folotyn-COP to the CHOP Regimen Alone in Newly Diagnosed Patients With Peripheral T-Cell Lymphoma","has_exemption":false,"start_date":"2023-10-04","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Acrotech Biopharma Inc.","sponsor_slug":"acrotech-biopharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05821855","publication_url":"https://clinicaltrials.gov/study/NCT05821855","title":"A Postmarketing Study Evaluating the Effectiveness and Safety of the XEN45 Glaucoma Treatment System in Subjects With Open-Angle Glaucoma in China","has_exemption":false,"start_date":"2024-01-09","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06461897","publication_url":"https://clinicaltrials.gov/study/NCT06461897","title":"A Phase 3, Open-label, Efficacy-Assessor-Blinded Study, Comparing the Safety and Efficacy of Upadacitinib to Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis","has_exemption":false,"start_date":"2024-08-19","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06577025","publication_url":"https://clinicaltrials.gov/study/NCT06577025","title":"A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of Different Sequences of Ciltacabtagene Autoleucel (Cilta-cel), Talquetamab SC in Combination With Daratumumab SC (Tal-D) and Teclistamab SC in Combination With Daratumumab SC (Tec-D) Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) in Participants With Standard-risk Newly Diagnosed Multiple Myeloma","has_exemption":false,"start_date":"2024-08-20","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07007273","publication_url":"https://clinicaltrials.gov/study/NCT07007273","title":"Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma","has_exemption":false,"start_date":"2025-06-20","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06992440","publication_url":"https://clinicaltrials.gov/study/NCT06992440","title":"Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension","has_exemption":false,"start_date":"2025-06-26","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Gustavo A Heresi, MD, MS","sponsor_slug":"gustavo-a-heresi-md-ms","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06950385","publication_url":"https://clinicaltrials.gov/study/NCT06950385","title":"A Phase 3, Multi-Site, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of eRapa to Improve Clinical Outcomes in Patients With Familial Adenomatous Polyposis","has_exemption":false,"start_date":"2025-07-18","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Rapamycin Holdings Inc.","sponsor_slug":"rapamycin-holdings-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07276035","publication_url":"https://clinicaltrials.gov/study/NCT07276035","title":"TMS Neuromodulation of Brain-to-Stomach Circuits in Chronic Nausea","has_exemption":false,"start_date":"2026-01-28","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"David Levinthal","sponsor_slug":"david-levinthal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06915233","publication_url":"https://clinicaltrials.gov/study/NCT06915233","title":"A Prospective, Open-label, Randomized, Concurrent Active-controlled, Longitudinal, Multicenter, Phase 3 Clinical Study of the Safety and Efficacy of MACI in Patients With Symptomatic Chondral or Osteochondral Lesions of the Talus (MASCOT)","has_exemption":false,"start_date":"2026-03-31","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Vericel Corporation","sponsor_slug":"vericel-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07227584","publication_url":"https://clinicaltrials.gov/study/NCT07227584","title":"Treatment of Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in Adolescents and Young Adults (AYAs)","has_exemption":false,"start_date":"2026-04-30","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07225543","publication_url":"https://clinicaltrials.gov/study/NCT07225543","title":"Scavenging IsoLGs in Autoimmune Disease: a Proof-of-concept Clinical Study","has_exemption":false,"start_date":"2026-05-15","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07211802","publication_url":"https://clinicaltrials.gov/study/NCT07211802","title":"Utilizing Continuous Ketone Monitors to Enable Safe Use of SGLT Inhibitors in Patients With Type 1 Diabetes","has_exemption":false,"start_date":"2026-07-01","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07176546","publication_url":"https://clinicaltrials.gov/study/NCT07176546","title":"TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis","has_exemption":false,"start_date":"2026-07-31","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Robert Spiera, MD","sponsor_slug":"robert-spiera-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07261241","publication_url":"https://clinicaltrials.gov/study/NCT07261241","title":"NANT 2021-02: A Randomized Phase 2 Study of 131I-MIBG With Vorinostat VS. 131I-MIBG With Dinutuximab vs. 131I-MIBG With Dinutuximab and Vorinostat for Relapsed or Refractory Neuroblastoma","has_exemption":false,"start_date":"2026-07-31","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"New Approaches to Neuroblastoma Therapy Consortium","sponsor_slug":"new-approaches-to-neuroblastoma-therapy-consortium","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07281768","publication_url":"https://clinicaltrials.gov/study/NCT07281768","title":"Combining Capecitabine/Oxaliplatin Chemotherapy With Cemiplimab Alone or in Combination With Fianlimab or REGN7075 for the Neoadjuvant Treatment of Locally Advanced Rectal Cancer","has_exemption":false,"start_date":"2026-07-31","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07408583","publication_url":"https://clinicaltrials.gov/study/NCT07408583","title":"A Phase I/II, Non-Randomized Study of the Safety and Efficacy of In Utero Hematopoietic Stem Cell Transplantation for the Treatment of Fanconi Anemia in Affected Fetuses","has_exemption":false,"start_date":"2026-07-31","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Agnieszka Czechowicz","sponsor_slug":"agnieszka-czechowicz","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07556237","publication_url":"https://clinicaltrials.gov/study/NCT07556237","title":"Gastric Electrical Stimulation for Abdominal Pain in Patients With Gastroparesis","has_exemption":false,"start_date":"2026-07-31","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Louisville","sponsor_slug":"university-of-louisville","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07137481","publication_url":"https://clinicaltrials.gov/study/NCT07137481","title":"Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies","has_exemption":false,"start_date":"2027-02-28","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07215013","publication_url":"https://clinicaltrials.gov/study/NCT07215013","title":"Acoustic Resonance Therapy for Treatment of Empty Nose Syndrome: A Prospective, Phase 2 Randomized Clinical Trial","has_exemption":false,"start_date":"2028-07-31","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05737693","publication_url":"https://clinicaltrials.gov/study/NCT05737693","title":"Posttraumatic Stress Disorder (PTSD) Treatment: Using Ketamine to Enhance Memory Reconsolidation and Extinction of Overgeneralized Fear in Individuals Diagnosed With PTSD","has_exemption":false,"start_date":"2023-08-21","completion_date":"2030-08-01","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06467344","publication_url":"https://clinicaltrials.gov/study/NCT06467344","title":"ACDN-01-001: Open-Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Subretinal ACDN-01 in Participants With ABCA4-related Retinopathy","has_exemption":false,"start_date":"2024-06-11","completion_date":"2030-08-01","has_results":false,"results_due":false,"sponsor_name":"Ascidian Therapeutics, Inc","sponsor_slug":"ascidian-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06843551","publication_url":"https://clinicaltrials.gov/study/NCT06843551","title":"A Phase 2 Single Arm Trial of Stereotactic Body Radiation Therapy Followed by Dual Immune Checkpoint Inhibition for Patients With Metastatic Pancreatic Ductal Adenocarcinoma - The Miami \"EMPIRE\" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation","has_exemption":false,"start_date":"2025-06-18","completion_date":"2030-08-01","has_results":false,"results_due":false,"sponsor_name":"Benjamin Spieler","sponsor_slug":"benjamin-spieler","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07516132","publication_url":"https://clinicaltrials.gov/study/NCT07516132","title":"A Phase 3b, Multicenter, Open-Label, Extension Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study","has_exemption":false,"start_date":"2026-04-01","completion_date":"2030-08-01","has_results":false,"results_due":false,"sponsor_name":"Ocular Therapeutix, Inc.","sponsor_slug":"ocular-therapeutix-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06976840","publication_url":"https://clinicaltrials.gov/study/NCT06976840","title":"Rapid Antidepressant Dynamics in Acute Neuromodulation Treatments","has_exemption":false,"start_date":"2026-05-31","completion_date":"2030-08-01","has_results":false,"results_due":false,"sponsor_name":"Marta Peciña MD PhD","sponsor_slug":"marta-pecina-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07277595","publication_url":"https://clinicaltrials.gov/study/NCT07277595","title":"KTMP: A Novel Method of Non-invasive Brain Stimulation to Enhance Motor Function in Chronic Stroke Patients.","has_exemption":false,"start_date":"2026-07-01","completion_date":"2030-08-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07521657","publication_url":"https://clinicaltrials.gov/study/NCT07521657","title":"Efficacy of Mirdametinib Alone or Combination With Radiotherapy for Germline and Sporadic NF1-Altered High-Grade Glioma","has_exemption":false,"start_date":"2026-08-01","completion_date":"2030-08-01","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07532252","publication_url":"https://clinicaltrials.gov/study/NCT07532252","title":"A Double-Blind Randomized Controlled Trial of Daridorexant for Alcohol Use Disorder","has_exemption":false,"start_date":"2027-01-01","completion_date":"2030-08-01","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04976322","publication_url":"https://clinicaltrials.gov/study/NCT04976322","title":"A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of Dapirolizumab Pegol Treatment in Study Participants With Systemic Lupus Erythematosus","has_exemption":false,"start_date":"2021-07-27","completion_date":"2030-08-07","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04300556","publication_url":"https://clinicaltrials.gov/study/NCT04300556","title":"A Multicenter, Open-Label Phase 1/2 Trial Evaluating the Safety, Tolerability, and Efficacy of MORAb-202, a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Subjects With Selected Tumor Types","has_exemption":false,"start_date":"2020-08-06","completion_date":"2030-08-08","has_results":false,"results_due":false,"sponsor_name":"Eisai Inc.","sponsor_slug":"eisai-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04579224","publication_url":"https://clinicaltrials.gov/study/NCT04579224","title":"A Phase III Randomized Trial of Eribulin (NSC #707389) With Gemcitabine Versus Standard of Care (Physician's Choice) for Treatment of Metastatic Urothelial Carcinoma Refractory to, or Ineligible for, Anti PD1/PDL1 Therapy","has_exemption":false,"start_date":"2021-06-28","completion_date":"2030-08-15","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06651970","publication_url":"https://clinicaltrials.gov/study/NCT06651970","title":"A Multicentre, Open-label, Randomised Phase IV Study to Investigate Acalabrutinib Monotherapy Compared to Investigator's Choice of Treatment in Adults (> 18 Years) With Chronic Lymphocytic Leukaemia and Moderate to Severe Cardiac Impairment","has_exemption":false,"start_date":"2025-02-04","completion_date":"2030-08-16","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06683755","publication_url":"https://clinicaltrials.gov/study/NCT06683755","title":"Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)","has_exemption":false,"start_date":"2025-05-01","completion_date":"2030-08-16","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07436728","publication_url":"https://clinicaltrials.gov/study/NCT07436728","title":"A Phase 1/2 First-in-Human, Open-Label, Dose Escalation and Expansion Trial of TAK-505 Monotherapy in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2026-04-29","completion_date":"2030-08-18","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02316379","publication_url":"https://clinicaltrials.gov/study/NCT02316379","title":"Use of Hyperpolarized 129Xe MR Lung Imaging in Adults for Calibration","has_exemption":false,"start_date":"2015-02-28","completion_date":"2030-08-24","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05983276","publication_url":"https://clinicaltrials.gov/study/NCT05983276","title":"Combination of the Hypomethylating Agent Decitabine and the Nuclear Export Receptor XPO-1 Inhibitor Selinexor to Reverse Platinum Resistance in Relapsed/Refractory Epithelial Ovarian Cancer","has_exemption":false,"start_date":"2023-11-16","completion_date":"2030-08-28","has_results":false,"results_due":false,"sponsor_name":"Loyola University","sponsor_slug":"loyola-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04877522","publication_url":"https://clinicaltrials.gov/study/NCT04877522","title":"An Open Label, Multi-center Asciminib Roll-over Study to Assess Long-term Safety in Patients Who Have Completed a Novartis Sponsored Asciminib Study and Are Judged by the Investigator to Benefit From Continued Treatment","has_exemption":false,"start_date":"2022-08-30","completion_date":"2030-08-29","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05451004","publication_url":"https://clinicaltrials.gov/study/NCT05451004","title":"SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer. A Phase III Randomized Controlled Trial","has_exemption":false,"start_date":"2023-02-10","completion_date":"2030-08-30","has_results":false,"results_due":false,"sponsor_name":"Canadian Cancer Trials Group","sponsor_slug":"canadian-cancer-trials-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07154706","publication_url":"https://clinicaltrials.gov/study/NCT07154706","title":"A Phase 3 Multicenter Double-blind Randomized Study of Taletrectinib Versus Placebo in Patients With ROS1-Fusion Positive Stage IB-IIIA Non-Small Cell Lung Cancer Who Have Undergone Complete Tumor Resection","has_exemption":false,"start_date":"2025-08-21","completion_date":"2030-08-30","has_results":false,"results_due":false,"sponsor_name":"Nuvation Bio, Inc.","sponsor_slug":"nuvation-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07227311","publication_url":"https://clinicaltrials.gov/study/NCT07227311","title":"A Phase 2, Multicenter, Open Label, Non-randomized Study to Evaluate the Efficacy and Safety of Extended Dosing of Belantamab Mafodotin in Different Combinations With Standard of Care Regimens in Participants With Relapsed-refractory Multiple Myeloma (DREAMM-15)","has_exemption":false,"start_date":"2026-04-15","completion_date":"2030-08-30","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07039422","publication_url":"https://clinicaltrials.gov/study/NCT07039422","title":"A Phase 2 Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab.","has_exemption":false,"start_date":"2026-04-27","completion_date":"2030-08-30","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07079111","publication_url":"https://clinicaltrials.gov/study/NCT07079111","title":"3D Printed Occlusal Splints for Intraoperative Use","has_exemption":false,"start_date":"2026-08-30","completion_date":"2030-08-30","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03396276","publication_url":"https://clinicaltrials.gov/study/NCT03396276","title":"Houston Emergency Opioid Engagement System (HEROES)","has_exemption":false,"start_date":"2018-04-01","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04811014","publication_url":"https://clinicaltrials.gov/study/NCT04811014","title":"Houston Emergency Engagement System for Youths and Adolescents","has_exemption":false,"start_date":"2021-04-19","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06051617","publication_url":"https://clinicaltrials.gov/study/NCT06051617","title":"AFFIRM: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis","has_exemption":false,"start_date":"2023-09-07","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07008469","publication_url":"https://clinicaltrials.gov/study/NCT07008469","title":"A Global Phase 3 Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Intravenous AOC 1001 for the Treatment of Myotonic Dystrophy Type 1","has_exemption":false,"start_date":"2025-07-25","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Avidity Biosciences, Inc.","sponsor_slug":"avidity-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07219485","publication_url":"https://clinicaltrials.gov/study/NCT07219485","title":"An Open-Label Study to Evaluate Safety of Pitolisant in Participants With Prader-Willi Syndrome","has_exemption":false,"start_date":"2025-08-20","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Harmony Biosciences Management, Inc.","sponsor_slug":"harmony-biosciences-management-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06948019","publication_url":"https://clinicaltrials.gov/study/NCT06948019","title":"Safety and Efficacy of AAV9/AP4B1 For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47): A Phase 1/2 Single-Center, Open-Label Study of Stereotactic Intra-cisterna Magna Administration","has_exemption":false,"start_date":"2025-08-31","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"BlackfinBio Ltd","sponsor_slug":"blackfinbio-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07022405","publication_url":"https://clinicaltrials.gov/study/NCT07022405","title":"Stratified Pharmacological Approaches for Regulating Circuit-Level Effects Study","has_exemption":false,"start_date":"2025-08-31","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07185256","publication_url":"https://clinicaltrials.gov/study/NCT07185256","title":"A Phase 1b/2a, Open-Label, Dose-Exploration Basket Study to Investigate the Safety and Tolerability of Subretinally Injected OPGx-BEST1 Administered in Patients With Either Autosomal-Dominant BEST1 Disease (Best Vitelliform Macular Dystrophy [BVMD]) or Autosomal-Recessive Bestrophinopathy (ARB)","has_exemption":false,"start_date":"2025-09-25","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Opus Genetics, Inc","sponsor_slug":"opus-genetics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07165028","publication_url":"https://clinicaltrials.gov/study/NCT07165028","title":"A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes","has_exemption":false,"start_date":"2025-10-15","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07303738","publication_url":"https://clinicaltrials.gov/study/NCT07303738","title":"The Use of High Bile-Binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations: A Novel Intervention for Children at Risk for Aspiration-Associated Complications (Aim 1)","has_exemption":false,"start_date":"2025-12-01","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07096297","publication_url":"https://clinicaltrials.gov/study/NCT07096297","title":"A Phase II Study of Luspatercept Plus Darbepoetin Alfa in Non-mutated SF3B1 Lower-risk Myelodysplastic Syndromes","has_exemption":false,"start_date":"2025-12-16","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07397559","publication_url":"https://clinicaltrials.gov/study/NCT07397559","title":"Spatiotemporal Control of Transcutaneous Spinal Cord Stimulation for Motor Function in SCI","has_exemption":false,"start_date":"2026-01-19","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07434492","publication_url":"https://clinicaltrials.gov/study/NCT07434492","title":"Smart Ankle-Foot Orthosis and 5-Azacitidine to Enhance Gait and Community Mobility for Children With Cerebral Palsy","has_exemption":false,"start_date":"2026-04-20","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Shirley Ryan AbilityLab","sponsor_slug":"shirley-ryan-abilitylab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07029529","publication_url":"https://clinicaltrials.gov/study/NCT07029529","title":"Phase 2 Study of Apremilast in Women and Men With Alcohol Use Disorder","has_exemption":false,"start_date":"2026-04-30","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07450677","publication_url":"https://clinicaltrials.gov/study/NCT07450677","title":"Neurobehavioral Effects of Visual Assistive Technologies","has_exemption":false,"start_date":"2026-06-01","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07227779","publication_url":"https://clinicaltrials.gov/study/NCT07227779","title":"A PHASE 2 NOVEL ANTIMICROBIAL COMBINATION THERAPY TO TREAT TUBERCULOUS MENINGITIS","has_exemption":false,"start_date":"2026-06-15","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07303868","publication_url":"https://clinicaltrials.gov/study/NCT07303868","title":"The Use of High Bile-Binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations: A Novel Intervention for Children at Risk for Aspiration-Associated Complications (Aim 2)","has_exemption":false,"start_date":"2026-07-31","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06131502","publication_url":"https://clinicaltrials.gov/study/NCT06131502","title":"ExAblate MR-guided Focused Ultrasound Bilateral Anterior Capsulotomy for Treatment of Obsessive-Compulsive Disorder","has_exemption":false,"start_date":"2026-08-31","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06841679","publication_url":"https://clinicaltrials.gov/study/NCT06841679","title":"A Multi-national, Open-label, Randomized Phase II/III Clinical Study of Utidelone Capsule (UTD2) Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma","has_exemption":false,"start_date":"2025-08-28","completion_date":"2030-09-01","has_results":false,"results_due":false,"sponsor_name":"Beijing Biostar Pharmaceuticals Co., Ltd.","sponsor_slug":"beijing-biostar-pharmaceuticals-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07164131","publication_url":"https://clinicaltrials.gov/study/NCT07164131","title":"Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams","has_exemption":false,"start_date":"2025-09-15","completion_date":"2030-09-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06827990","publication_url":"https://clinicaltrials.gov/study/NCT06827990","title":"Evaluation of the GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections","has_exemption":false,"start_date":"2025-09-22","completion_date":"2030-09-01","has_results":false,"results_due":false,"sponsor_name":"W.L.Gore & Associates","sponsor_slug":"wlgore-associates","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07153003","publication_url":"https://clinicaltrials.gov/study/NCT07153003","title":"Efficacy And Safety Of Tramadol And Oxycodone Versus Oxycodone Monotherapy For Pain Control After Primary Total Knee And Total Hip Arthroplasty: A Prospective Randomized Controlled Trial","has_exemption":false,"start_date":"2026-02-02","completion_date":"2030-09-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07228624","publication_url":"https://clinicaltrials.gov/study/NCT07228624","title":"Peri-Hematopoietic Cell Transplantation Ruxolitinib in Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes","has_exemption":false,"start_date":"2026-02-04","completion_date":"2030-09-01","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07288450","publication_url":"https://clinicaltrials.gov/study/NCT07288450","title":"Terazosin And Metabolic Engagement in Parkinson's Disease","has_exemption":false,"start_date":"2026-09-01","completion_date":"2030-09-01","has_results":false,"results_due":false,"sponsor_name":"Nandakumar Narayanan","sponsor_slug":"nandakumar-narayanan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06794944","publication_url":"https://clinicaltrials.gov/study/NCT06794944","title":"Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease","has_exemption":false,"start_date":"2026-09-30","completion_date":"2030-09-01","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07470489","publication_url":"https://clinicaltrials.gov/study/NCT07470489","title":"A Multi-Center Single-Arm Phase 2 Trial Of Zanzalintinib In Combination With Cemiplimab In BRAF Wild-Type Anaplastic Thyroid Cancer: The ZEPHYR Trial","has_exemption":false,"start_date":"2026-09-30","completion_date":"2030-09-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05987241","publication_url":"https://clinicaltrials.gov/study/NCT05987241","title":"MODERN: An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of ADjuvant ThErapy in URothelial CaNcer","has_exemption":false,"start_date":"2024-02-02","completion_date":"2030-09-02","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04246086","publication_url":"https://clinicaltrials.gov/study/NCT04246086","title":"A Phase Ib/II, Open-Label, Multicenter Study With a Non-Randomized Stage Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab Plus Lenalidomide (+Len), and a Randomized Stage Evaluating the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Patients With Follicular Lymphoma","has_exemption":false,"start_date":"2020-08-12","completion_date":"2030-09-06","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07470879","publication_url":"https://clinicaltrials.gov/study/NCT07470879","title":"A PHASE 2 OPEN-LABEL, SINGLE ARM STUDY TO EVALUATE THE EFFICACY, PHARMACOKINETICS, AND SAFETY OF ETRASIMOD IN PEDIATRIC PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS","has_exemption":false,"start_date":"2026-05-30","completion_date":"2030-09-10","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07361497","publication_url":"https://clinicaltrials.gov/study/NCT07361497","title":"ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants With Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.","has_exemption":false,"start_date":"2026-03-16","completion_date":"2030-09-18","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05335876","publication_url":"https://clinicaltrials.gov/study/NCT05335876","title":"Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 IT or OAV101 IV in Clinical Trials","has_exemption":false,"start_date":"2022-12-19","completion_date":"2030-09-26","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07173803","publication_url":"https://clinicaltrials.gov/study/NCT07173803","title":"The Progressive Supranuclear Palsy Clinical Trial Platform","has_exemption":false,"start_date":"2026-06-30","completion_date":"2030-09-28","has_results":false,"results_due":false,"sponsor_name":"Adam Boxer","sponsor_slug":"adam-boxer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217665","publication_url":"https://clinicaltrials.gov/study/NCT07217665","title":"The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1","has_exemption":false,"start_date":"2026-06-30","completion_date":"2030-09-28","has_results":false,"results_due":false,"sponsor_name":"Adam Boxer","sponsor_slug":"adam-boxer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07264283","publication_url":"https://clinicaltrials.gov/study/NCT07264283","title":"The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31","has_exemption":false,"start_date":"2026-06-30","completion_date":"2030-09-28","has_results":false,"results_due":false,"sponsor_name":"Adam Boxer","sponsor_slug":"adam-boxer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02559778","publication_url":"https://clinicaltrials.gov/study/NCT02559778","title":"A Study Using Molecular Guided Therapy With Induction Chemotherapy Followed by a Randomized Controlled Trial of Standard Immunotherapy With or Without DFMO Followed by DFMO Maintenance for Subjects With Newly Diagnosed High-Risk Neuroblastoma","has_exemption":false,"start_date":"2015-09-30","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"Giselle Sholler","sponsor_slug":"giselle-sholler","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03143374","publication_url":"https://clinicaltrials.gov/study/NCT03143374","title":"Positron Emission Tomography (PET) Imaging of Tau Pathology in Neurodegenerative Disease","has_exemption":false,"start_date":"2016-08-23","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03034811","publication_url":"https://clinicaltrials.gov/study/NCT03034811","title":"Persona Partial Knee Clinical Outcomes Study","has_exemption":false,"start_date":"2017-02-08","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"Zimmer Biomet","sponsor_slug":"zimmer-biomet","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03424005","publication_url":"https://clinicaltrials.gov/study/NCT03424005","title":"A Phase Ib/II, Open-label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic Breast Cancer (Morpheus-panBC)","has_exemption":false,"start_date":"2018-03-30","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03126916","publication_url":"https://clinicaltrials.gov/study/NCT03126916","title":"A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)","has_exemption":false,"start_date":"2018-05-14","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04685616","publication_url":"https://clinicaltrials.gov/study/NCT04685616","title":"A Randomised Phase III Trial With a PET Response Adapted Design Comparing ABVD +/- ISRT With A2VD +/- ISRT in Patients With Previously Untreated Stage IA/IIA Hodgkin Lymphoma","has_exemption":false,"start_date":"2022-04-14","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"University College, London","sponsor_slug":"university-college-london","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05450653","publication_url":"https://clinicaltrials.gov/study/NCT05450653","title":"Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Fetuses With Severe Congenital Diaphragmatic Hernia (CDH)","has_exemption":false,"start_date":"2022-09-18","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"Aimen F. Shaaban, MD","sponsor_slug":"aimen-f-shaaban-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06109272","publication_url":"https://clinicaltrials.gov/study/NCT06109272","title":"A Phase 2/3, Randomized Study to Evaluate the Dose Optimization, Safety, and Efficacy of Livmoniplimab in Combination With Budigalimab in Subjects With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) Who Have Not Previously Received Systemic Treatment","has_exemption":false,"start_date":"2024-01-11","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06441955","publication_url":"https://clinicaltrials.gov/study/NCT06441955","title":"Covid-19 Long Haul Syndrome: Undiagnosed Disorder Post Covid-19 Alternative Treatment Study.","has_exemption":false,"start_date":"2024-03-01","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"Well- Konnect Healthcare Services and Research Firm","sponsor_slug":"well-konnect-healthcare-services-and-research-firm","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05673018","publication_url":"https://clinicaltrials.gov/study/NCT05673018","title":"REACH Study: Galleri® in the Medicare Population.","has_exemption":false,"start_date":"2024-07-12","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"GRAIL, Inc.","sponsor_slug":"grail-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06475989","publication_url":"https://clinicaltrials.gov/study/NCT06475989","title":"A Randomized Phase III Study of BRAF-Targeted Therapy vs Cabozantinib in RAI-Refractory Differentiated Thyroid Cancer With BRAF V600Em","has_exemption":false,"start_date":"2024-08-22","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"ECOG-ACRIN Cancer Research Group","sponsor_slug":"ecog-acrin-cancer-research-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06518785","publication_url":"https://clinicaltrials.gov/study/NCT06518785","title":"Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder","has_exemption":false,"start_date":"2025-01-07","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06861244","publication_url":"https://clinicaltrials.gov/study/NCT06861244","title":"PNOC031: Protocol for Embryonal Tumor With Multilayered Rosettes (ETMR)","has_exemption":false,"start_date":"2025-03-06","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06953882","publication_url":"https://clinicaltrials.gov/study/NCT06953882","title":"SELECT: A Phase II Adjuvant Trial Evaluating the Impact of Omitting Chemotherapy Based on Patient's Selection for Moderate to High-Anatomical Risk, Low-Genomic Risk, ER-Positive, HER2- Negative Breast Cancer With a Combination Regimen of Ribociclib and Optimized Endocrine Therapy","has_exemption":false,"start_date":"2025-07-09","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07096362","publication_url":"https://clinicaltrials.gov/study/NCT07096362","title":"A Phase 2 Study Assessing Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma","has_exemption":false,"start_date":"2025-09-09","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06997081","publication_url":"https://clinicaltrials.gov/study/NCT06997081","title":"Elranatamab, Lenalidomide, Dexamethasone in Newly Diagnosed Multiple Myeloma, a Clinical and Correlative Phase 2 Study","has_exemption":false,"start_date":"2025-09-16","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07181109","publication_url":"https://clinicaltrials.gov/study/NCT07181109","title":"ZENITH: A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease","has_exemption":false,"start_date":"2025-09-22","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"Alnylam Pharmaceuticals","sponsor_slug":"alnylam-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07158476","publication_url":"https://clinicaltrials.gov/study/NCT07158476","title":"Efficacy of Methylprednisolone for Pain Control After ACL Repair: A Randomized Controlled Trial","has_exemption":false,"start_date":"2025-10-21","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"St. Louis University","sponsor_slug":"st-louis-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221539","publication_url":"https://clinicaltrials.gov/study/NCT07221539","title":"Restoration of Consciousness With Ultrasonic Deep Brain Stimulation During Anesthetic Sedation","has_exemption":false,"start_date":"2025-10-24","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07214207","publication_url":"https://clinicaltrials.gov/study/NCT07214207","title":"Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking","has_exemption":false,"start_date":"2025-12-04","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07155187","publication_url":"https://clinicaltrials.gov/study/NCT07155187","title":"Phase 2/3 Open Label Randomized Study of Telisotuzumab Adizutecan Compared to Standard of Care in Subjects With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer After Progression on a Third-Generation EGFR TKI","has_exemption":false,"start_date":"2025-12-10","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07424846","publication_url":"https://clinicaltrials.gov/study/NCT07424846","title":"Xylitol and the Prevention of Periodontal Disease and Preterm Birth (XaPPP) Trial","has_exemption":false,"start_date":"2026-03-15","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07365241","publication_url":"https://clinicaltrials.gov/study/NCT07365241","title":"A Phase 3 Randomized, Open Label, Multicenter Study to Evaluate the Safety and Efficacy of ABBV-706 Versus Standard of Care in Subjects With Relapsed/Refractory Small Cell Lung Cancer (SCLC)","has_exemption":false,"start_date":"2026-04-14","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07225985","publication_url":"https://clinicaltrials.gov/study/NCT07225985","title":"Pralatrexate and Bendamustine With 3 Gy TBI as a New Reduced Intensity Conditioning (RIC) Regimen for Allogeneic HCT for T-Cell Lymphoma Patients Who Are in Untreated R/R, or in Remission With MRD","has_exemption":false,"start_date":"2026-04-27","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07088120","publication_url":"https://clinicaltrials.gov/study/NCT07088120","title":"PRecision-Controlled Ventilation to Enhance Cardiac Arrest Intervention and Survival IN CPR: A Multi-Center Randomized Controlled Trial","has_exemption":false,"start_date":"2026-09-01","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07485335","publication_url":"https://clinicaltrials.gov/study/NCT07485335","title":"Implementation and Effectiveness of A Bundled Intervention to End Opioid Overdoses by Increasing Treatment Uptake Post Discharge","has_exemption":false,"start_date":"2026-09-07","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07337655","publication_url":"https://clinicaltrials.gov/study/NCT07337655","title":"A Phase II/III Clinical Trial Evaluating the Efficacy and Safety of Aspirin and Lansoprazole in High-Risk Pregnant Women for the Prevention of Preterm Birth: A Biomarker-Enriched Design","has_exemption":false,"start_date":"2026-10-01","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07568860","publication_url":"https://clinicaltrials.gov/study/NCT07568860","title":"Sleep-Driven Adaptive Neuromodulation in Lennox-Gastaut Syndrome","has_exemption":false,"start_date":"2026-10-01","completion_date":"2030-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06034821","publication_url":"https://clinicaltrials.gov/study/NCT06034821","title":"Rapid Reversal of Suicidal Depression: Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan (REaKT-SD)","has_exemption":false,"start_date":"2023-10-01","completion_date":"2030-10-01","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07240922","publication_url":"https://clinicaltrials.gov/study/NCT07240922","title":"The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study - a Randomized Controlled Trial","has_exemption":false,"start_date":"2025-10-01","completion_date":"2030-10-01","has_results":false,"results_due":false,"sponsor_name":"The University of Hong Kong","sponsor_slug":"the-university-of-hong-kong","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06942442","publication_url":"https://clinicaltrials.gov/study/NCT06942442","title":"A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma","has_exemption":false,"start_date":"2025-10-22","completion_date":"2030-10-01","has_results":false,"results_due":false,"sponsor_name":"Sarcoma Alliance for Research through Collaboration","sponsor_slug":"sarcoma-alliance-for-research-through-collaboration","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07075510","publication_url":"https://clinicaltrials.gov/study/NCT07075510","title":"A Phase I/II Study of Subcutaneous Daratumumab Administration in the Anterior Upper Thigh Vs Abdomen in Patients With Plasma Cell Disorders","has_exemption":false,"start_date":"2025-10-23","completion_date":"2030-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07209189","publication_url":"https://clinicaltrials.gov/study/NCT07209189","title":"Neoadjuvant Chemotherapy and PD-1 Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)","has_exemption":false,"start_date":"2026-02-18","completion_date":"2030-10-01","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07098364","publication_url":"https://clinicaltrials.gov/study/NCT07098364","title":"A Phase 1/2 Open-Label Study Evaluating the Safety and Efficacy of ST-067 in Combination With CD19-Directed CAR T-Cell Therapy in Patients With Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)","has_exemption":false,"start_date":"2025-12-27","completion_date":"2030-10-04","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07192237","publication_url":"https://clinicaltrials.gov/study/NCT07192237","title":"Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia","has_exemption":false,"start_date":"2026-09-27","completion_date":"2030-10-12","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04270409","publication_url":"https://clinicaltrials.gov/study/NCT04270409","title":"A Phase 3 Randomized, Open-label, Multicenter Study of Isatuximab (SAR650984) in Combination With Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With High-risk Smoldering Multiple Myeloma","has_exemption":false,"start_date":"2020-06-16","completion_date":"2030-10-14","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06525766","publication_url":"https://clinicaltrials.gov/study/NCT06525766","title":"Single Arm Pilot Trial of Adaptive Therapy (AT) With Capecitabine for the Treatment of Metastatic Estrogen Receptor Positive, Hormone Refractory Breast Cancer","has_exemption":false,"start_date":"2025-10-01","completion_date":"2030-10-15","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05623020","publication_url":"https://clinicaltrials.gov/study/NCT05623020","title":"AN OPEN-LABEL, 2-ARM, MULTICENTER, RANDOMIZED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ELRANATAMAB (PF-06863135) + DARATUMUMAB + LENALIDOMIDE VERSUS DARATUMUMAB + BORTEZOMIB + LENALIDOMIDE + DEXAMETHASONE IN TRANSPLANT-INELIGIBLE PARTICIPANTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA","has_exemption":false,"start_date":"2022-11-10","completion_date":"2030-10-18","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06669117","publication_url":"https://clinicaltrials.gov/study/NCT06669117","title":"A First-In-Human (FIH) Phase I/II Open-label, Multicentre, Dose Escalation and Expansion Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors Including Non-small Cell Lung Cancer (NSCLC) Harboring Mesenchymal-Epithelial Transition (MET) Alterations","has_exemption":false,"start_date":"2024-10-22","completion_date":"2030-10-21","has_results":false,"results_due":false,"sponsor_name":"Pierre Fabre Medicament","sponsor_slug":"pierre-fabre-medicament","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04545957","publication_url":"https://clinicaltrials.gov/study/NCT04545957","title":"Judging MR Simulation Procedures: A Phase I-II Study of the Use of Magnetic Resonance Imaging Simulation in the Planning of Radiation Treatments","has_exemption":false,"start_date":"2020-10-14","completion_date":"2030-10-22","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06646289","publication_url":"https://clinicaltrials.gov/study/NCT06646289","title":"An Open-label, Multicenter, Phase 2 Follow-on Study for Second Eye Treatment of Patients Previously Treated With a Recombinant Adeno-associated Virus Vector (AAV5 hRKp.RPGR) for Gene Therapy of Adults and Children With X-linked Retinitis Pigmentosa Owing to Defects in Retinitis Pigmentosa GTPase Regulator (RPGR)","has_exemption":false,"start_date":"2024-10-10","completion_date":"2030-10-24","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07363694","publication_url":"https://clinicaltrials.gov/study/NCT07363694","title":"AN INTERVENTIONAL PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, THIRD PARTY-UNBLINDED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO INVESTIGATE EFFICACY AND SAFETY OF PF-07275315 IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)","has_exemption":false,"start_date":"2026-02-11","completion_date":"2030-10-24","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07468136","publication_url":"https://clinicaltrials.gov/study/NCT07468136","title":"Phase I/IIa Trial of Retifanlimab and Difluoromethylornithine (DFMO) in Patients With Progressive High-Grade Glioma","has_exemption":false,"start_date":"2026-04-24","completion_date":"2030-10-25","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07222956","publication_url":"https://clinicaltrials.gov/study/NCT07222956","title":"An Open-label, Single-center Study of Remibrutinib Using Ultra High-field (7T) MR Imaging in Relapsing or Progressive MS (RemiSeven)","has_exemption":false,"start_date":"2026-04-01","completion_date":"2030-10-30","has_results":false,"results_due":false,"sponsor_name":"Moein Amin","sponsor_slug":"moein-amin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00160732","publication_url":"https://clinicaltrials.gov/study/NCT00160732","title":"Allogenic Islet Cells (Human, U. of Chicago) Administered Via Intraportal Infusion; and Immunosuppressive Therapy","has_exemption":false,"start_date":"2003-10-31","completion_date":"2030-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04062266","publication_url":"https://clinicaltrials.gov/study/NCT04062266","title":"Phase II Study of 5-Azacytidine (AZA) + Venetoclax as Maintenance Therapy in Patients With AML in Remission","has_exemption":false,"start_date":"2019-09-13","completion_date":"2030-10-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04584853","publication_url":"https://clinicaltrials.gov/study/NCT04584853","title":"PreOperative Endocrine Therapy for Individualised Care With Abemaciclib","has_exemption":false,"start_date":"2020-12-23","completion_date":"2030-10-31","has_results":false,"results_due":false,"sponsor_name":"Institute of Cancer Research, United Kingdom","sponsor_slug":"institute-of-cancer-research-united-kingdom","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04948619","publication_url":"https://clinicaltrials.gov/study/NCT04948619","title":"Immune Function and Response to Vaccination Following Completion of Cancer Directed Systemic Therapy in Pediatric Patients With Cancer","has_exemption":false,"start_date":"2022-08-08","completion_date":"2030-10-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05371093","publication_url":"https://clinicaltrials.gov/study/NCT05371093","title":"A Phase 3 Randomized, Open-Label, Multicenter Study Evaluating the Efficacy of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Subjects With Relapsed/Refractory Follicular Lymphoma","has_exemption":false,"start_date":"2022-09-22","completion_date":"2030-10-31","has_results":false,"results_due":false,"sponsor_name":"Kite, A Gilead Company","sponsor_slug":"kite-a-gilead-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07142408","publication_url":"https://clinicaltrials.gov/study/NCT07142408","title":"The Effect of Pre-Operative Bacterial Decolonization on Post-Operative Infection Rate for Lower Extremity Wounds Healing by Second Intention","has_exemption":false,"start_date":"2023-03-13","completion_date":"2030-10-31","has_results":false,"results_due":false,"sponsor_name":"The Cooper Health System","sponsor_slug":"the-cooper-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05933395","publication_url":"https://clinicaltrials.gov/study/NCT05933395","title":"Genetically-informed Therapy for ER+ Breast Cancer in a Post-CDK4/6 Inhibitor Setting: a Phase II Umbrella Study (GERTRUDE)","has_exemption":false,"start_date":"2024-09-23","completion_date":"2030-10-31","has_results":false,"results_due":false,"sponsor_name":"Dartmouth-Hitchcock Medical Center","sponsor_slug":"dartmouth-hitchcock-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06121180","publication_url":"https://clinicaltrials.gov/study/NCT06121180","title":"A Phase II Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma","has_exemption":false,"start_date":"2024-11-04","completion_date":"2030-10-31","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06628310","publication_url":"https://clinicaltrials.gov/study/NCT06628310","title":"A Phase 2 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination With Fluorouracil, Leucovorin, and Budigalimab as First-Line Treatment in Subjects With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (AndroMETa-GEA-977)","has_exemption":false,"start_date":"2024-12-13","completion_date":"2030-10-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06626516","publication_url":"https://clinicaltrials.gov/study/NCT06626516","title":"A Phase I/II Study of Tebentafusp-tebn in Combination With Liver-Directed Therapies for the Treatment of Metastatic Uveal Melanoma","has_exemption":false,"start_date":"2025-10-15","completion_date":"2030-10-31","has_results":false,"results_due":false,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07216248","publication_url":"https://clinicaltrials.gov/study/NCT07216248","title":"A Phase II Randomized, Decentralized, De-escalation Study in Patients With Metastatic Hormone-Sensitive Prostate Cancer Achieving Optimal PSA Response (OPTIMAS)","has_exemption":false,"start_date":"2025-10-27","completion_date":"2030-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05213676","publication_url":"https://clinicaltrials.gov/study/NCT05213676","title":"Inhaled Nitric Oxide (iNO) for Congenital Diaphragmatic Hernia (CDH) - The \"NoNO Trial\" - a Multi-center, De-implementation, Stepped-wedge, Cluster-randomized Trial Within an Established Collaborative","has_exemption":false,"start_date":"2025-11-01","completion_date":"2030-10-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07150715","publication_url":"https://clinicaltrials.gov/study/NCT07150715","title":"Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide Combined With Metastasis-Directed Stereotactic Body Radiotherapy for Oligorecurrent Prostate Adenocarcinoma (ANDROMEDA)","has_exemption":false,"start_date":"2025-12-12","completion_date":"2030-10-31","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07265947","publication_url":"https://clinicaltrials.gov/study/NCT07265947","title":"A Phase 2A/B, Multi-center, Open-Label Study Evaluating the Efficacy and Safety of Dabogratinib (TYRA-300) in Participants With Low Grade Upper Tract Urothelial Carcinoma (SURF303)","has_exemption":false,"start_date":"2025-12-22","completion_date":"2030-10-31","has_results":false,"results_due":false,"sponsor_name":"Tyra Biosciences, Inc","sponsor_slug":"tyra-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07015190","publication_url":"https://clinicaltrials.gov/study/NCT07015190","title":"A Randomized, Phase 3, Open-label Study of Neoadjuvant Darovasertib in Subjects With Primary Non-metastatic Uveal Melanoma (OptimUM-10)","has_exemption":false,"start_date":"2026-01-25","completion_date":"2030-10-31","has_results":false,"results_due":false,"sponsor_name":"IDEAYA Biosciences","sponsor_slug":"ideaya-biosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03244072","publication_url":"https://clinicaltrials.gov/study/NCT03244072","title":"Safety and Efficacy of Intracameral Zimoxin (0.1% Moxifloxacin Solution) for Prevention of Endophthalmitis After Cataract Surgery","has_exemption":false,"start_date":"2026-06-01","completion_date":"2030-10-31","has_results":false,"results_due":false,"sponsor_name":"Jason Ahee, M.D.","sponsor_slug":"jason-ahee-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07148843","publication_url":"https://clinicaltrials.gov/study/NCT07148843","title":"Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving","has_exemption":false,"start_date":"2026-08-01","completion_date":"2030-10-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07528690","publication_url":"https://clinicaltrials.gov/study/NCT07528690","title":"Microbiota Transplant Therapy to Prevent HE Recurrence in a Phase 2B Multi-Center Trial of Veterans With Cirrhosis","has_exemption":false,"start_date":"2026-10-30","completion_date":"2030-10-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04760860","publication_url":"https://clinicaltrials.gov/study/NCT04760860","title":"a Randomized, Double Blind, Placebo Controlled Clinical Trial Exploring the Target Engagement and Tolerability of Terazosin Hydrochloride in Patients With Dementia With Lewy Bodies","has_exemption":false,"start_date":"2027-10-31","completion_date":"2030-10-31","has_results":false,"results_due":false,"sponsor_name":"Qiang Zhang","sponsor_slug":"qiang-zhang","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06458036","publication_url":"https://clinicaltrials.gov/study/NCT06458036","title":"Selpercatinib to Enhance RAI Avidity in Children, Adolescents, and Young Adults With Newly Diagnosed Differentiated Thyroid Cancers Harboring RET Fusions","has_exemption":false,"start_date":"2024-07-29","completion_date":"2030-11-01","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Philadelphia","sponsor_slug":"childrens-hospital-of-philadelphia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06541262","publication_url":"https://clinicaltrials.gov/study/NCT06541262","title":"Phase I/II Study of Silmitasertib (CX-4945) in Combination With Chemotherapy in Children and Young Adults With Relapsed Refractory Solid Tumors","has_exemption":false,"start_date":"2024-10-30","completion_date":"2030-11-01","has_results":false,"results_due":false,"sponsor_name":"Milton S. Hershey Medical Center","sponsor_slug":"milton-s-hershey-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06906887","publication_url":"https://clinicaltrials.gov/study/NCT06906887","title":"PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer","has_exemption":false,"start_date":"2025-06-17","completion_date":"2030-11-01","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06926595","publication_url":"https://clinicaltrials.gov/study/NCT06926595","title":"Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) With Low-Dose Post-Transplant Cyclophosphamide for Prophylaxis of Graft-versus-Host Disease in Hematological Malignancies","has_exemption":false,"start_date":"2026-03-09","completion_date":"2030-11-01","has_results":false,"results_due":false,"sponsor_name":"Milton S. Hershey Medical Center","sponsor_slug":"milton-s-hershey-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06934655","publication_url":"https://clinicaltrials.gov/study/NCT06934655","title":"Early Re-Initiation of Semaglutide Post Sleeve Gastrectomy in Youth","has_exemption":false,"start_date":"2026-06-01","completion_date":"2030-11-01","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Los Angeles","sponsor_slug":"childrens-hospital-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07322341","publication_url":"https://clinicaltrials.gov/study/NCT07322341","title":"A Phase 2 Trial of SX-682 and Atezolizumab in Patients With Advanced NSCLC Who Progressed on Prior Chemotherapy and Immune Checkpoint Inhibitor (ICI) Therapy","has_exemption":false,"start_date":"2026-06-01","completion_date":"2030-11-01","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07136428","publication_url":"https://clinicaltrials.gov/study/NCT07136428","title":"A Single Arm, Open-label Phase Ib/II Study of Asciminib in HER2+ Breast Cancer Brain Metastases (ASCENdANT)","has_exemption":false,"start_date":"2026-07-31","completion_date":"2030-11-01","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03750227","publication_url":"https://clinicaltrials.gov/study/NCT03750227","title":"Pre-Operative vs. Post-Operative Stereotactic Radiosurgery for Operative Metastatic Brain Tumors","has_exemption":false,"start_date":"2018-11-19","completion_date":"2030-11-08","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221149","publication_url":"https://clinicaltrials.gov/study/NCT07221149","title":"ROSETTA Gastric-204: A Blinded, Randomized, Phase 2/3 Study of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma","has_exemption":false,"start_date":"2026-03-13","completion_date":"2030-11-08","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06995508","publication_url":"https://clinicaltrials.gov/study/NCT06995508","title":"Managing Anorexia During Chemoradiation With Olanzapine (MACRO)","has_exemption":false,"start_date":"2025-12-24","completion_date":"2030-11-15","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07050186","publication_url":"https://clinicaltrials.gov/study/NCT07050186","title":"A Single Arm Open-Label Pilot Study to Investigate the Safety and Clinical Activity of Cemiplimab, A Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients With Incurable NUT Carcinoma (NC)","has_exemption":false,"start_date":"2025-08-15","completion_date":"2030-11-20","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05295290","publication_url":"https://clinicaltrials.gov/study/NCT05295290","title":"Low Interventional Cohort Study of Myocarditis/Pericarditis Associated With COMIRNATY in Persons Less Than 21 Years of Age","has_exemption":false,"start_date":"2022-11-21","completion_date":"2030-11-21","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06128070","publication_url":"https://clinicaltrials.gov/study/NCT06128070","title":"Phase 2a Study of Adding Ruxolitinib With Tacrolimus/Methotrexate Regimen for Graft-versus-Host Disease Prophylaxis in Myeloablative Conditioning Hematopoietic Cell Transplantation in Pediatric and Young Adult Patients","has_exemption":false,"start_date":"2024-07-16","completion_date":"2030-11-22","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06211764","publication_url":"https://clinicaltrials.gov/study/NCT06211764","title":"A Phase 3, Randomized, Open-label, Multi-center Study Evaluating the Efficacy and Safety of TAR-200 Versus Investigator's Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High-risk Non-muscle-invasive Bladder Cancer (HR-NMIBC) and Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy","has_exemption":false,"start_date":"2024-04-09","completion_date":"2030-11-27","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07489495","publication_url":"https://clinicaltrials.gov/study/NCT07489495","title":"A Phase 3, Randomized, Double-blind, Study of Belzutifan + Zanzalintinib Versus Belzutifan + Placebo in Participants With Advanced RCC Who Have Progressed on or After Both PD-1/L1 and VEGF-TKI Therapies in Sequence or in Combination (LITESPARK-034)","has_exemption":false,"start_date":"2026-04-09","completion_date":"2030-11-27","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07227597","publication_url":"https://clinicaltrials.gov/study/NCT07227597","title":"A Phase 1b/2 Open-label Study Evaluating Different MK-6070 and Ifinatamab Deruxtecan (MK-2400)-Based Regimens in First-line Extensive Stage Small Cell Lung Cancer","has_exemption":false,"start_date":"2026-01-29","completion_date":"2030-11-29","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07498335","publication_url":"https://clinicaltrials.gov/study/NCT07498335","title":"A Single-arm, Multicenter, Phase III Study to Assess Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients of 2 to <18 Years of Age With Primary Immunoglobulin A Nephropathy (IgAN)","has_exemption":false,"start_date":"2026-10-02","completion_date":"2030-11-29","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03587272","publication_url":"https://clinicaltrials.gov/study/NCT03587272","title":"Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease","has_exemption":false,"start_date":"2018-04-17","completion_date":"2030-11-30","has_results":false,"results_due":false,"sponsor_name":"Robert Nickel","sponsor_slug":"robert-nickel","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04927416","publication_url":"https://clinicaltrials.gov/study/NCT04927416","title":"The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer","has_exemption":false,"start_date":"2021-10-25","completion_date":"2030-11-30","has_results":false,"results_due":false,"sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","sponsor_slug":"national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06185673","publication_url":"https://clinicaltrials.gov/study/NCT06185673","title":"A Phase 1b/2a, Open-label, Dose Escalation Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia","has_exemption":false,"start_date":"2023-11-28","completion_date":"2030-11-30","has_results":false,"results_due":false,"sponsor_name":"Benitec Biopharma, Inc.","sponsor_slug":"benitec-biopharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06169371","publication_url":"https://clinicaltrials.gov/study/NCT06169371","title":"Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)","has_exemption":false,"start_date":"2023-12-28","completion_date":"2030-11-30","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06462547","publication_url":"https://clinicaltrials.gov/study/NCT06462547","title":"The ADAPT Study: An Open-label, Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency","has_exemption":false,"start_date":"2024-06-19","completion_date":"2030-11-30","has_results":false,"results_due":false,"sponsor_name":"Inozyme Pharma","sponsor_slug":"inozyme-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06608927","publication_url":"https://clinicaltrials.gov/study/NCT06608927","title":"A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 3 Trial of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Treatment-Naive Metastatic Pancreatic Ductal Adenocarcinoma","has_exemption":false,"start_date":"2024-12-13","completion_date":"2030-11-30","has_results":false,"results_due":false,"sponsor_name":"Arcus Biosciences, Inc.","sponsor_slug":"arcus-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06593093","publication_url":"https://clinicaltrials.gov/study/NCT06593093","title":"A Bundled Intervention to End Opioid Overdose by Increasing Treatment Uptake Post Emergency Department Discharge","has_exemption":false,"start_date":"2025-02-13","completion_date":"2030-11-30","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06649357","publication_url":"https://clinicaltrials.gov/study/NCT06649357","title":"Comparison Between Bipolar Transurethral Resection of the Prostate and Moses Assisted Holmium Laser Enucleation of the Prostate. A Prospective Randomized Multicentric Study","has_exemption":false,"start_date":"2025-04-01","completion_date":"2030-11-30","has_results":false,"results_due":false,"sponsor_name":"Fundacio Puigvert","sponsor_slug":"fundacio-puigvert","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06798909","publication_url":"https://clinicaltrials.gov/study/NCT06798909","title":"Kidney Transplant Preemptive Therapy or Prophylaxis (KPoP) for CMV Prevention in D+R- Recipients","has_exemption":false,"start_date":"2025-07-22","completion_date":"2030-11-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07223424","publication_url":"https://clinicaltrials.gov/study/NCT07223424","title":"Patient Preference for Subcutaneous vs. Intravenous Immune Therapy (PSI-Immune)","has_exemption":false,"start_date":"2025-11-04","completion_date":"2030-11-30","has_results":false,"results_due":false,"sponsor_name":"Diwakar Davar","sponsor_slug":"diwakar-davar","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07227636","publication_url":"https://clinicaltrials.gov/study/NCT07227636","title":"Phase II Study of Adjuvant Botensilimab in Combination With Balstilimab in Patients With Colorectal Cancer and Persistent Circulating Tumor DNA Following Surgery and Chemotherapy","has_exemption":false,"start_date":"2025-11-07","completion_date":"2030-11-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07194590","publication_url":"https://clinicaltrials.gov/study/NCT07194590","title":"Equol Supplementation for Improving Vascular Function in Postmenopausal Women With CKD","has_exemption":false,"start_date":"2025-12-01","completion_date":"2030-11-30","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07270991","publication_url":"https://clinicaltrials.gov/study/NCT07270991","title":"Randomized Phase III Trial to Compare Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma","has_exemption":false,"start_date":"2025-12-15","completion_date":"2030-11-30","has_results":false,"results_due":false,"sponsor_name":"Federation Francophone de Cancerologie Digestive","sponsor_slug":"federation-francophone-de-cancerologie-digestive","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220616","publication_url":"https://clinicaltrials.gov/study/NCT07220616","title":"A Phase 1/2, Multicenter, Open-Label, Multi-Cohort, First-in Human Trial of DS3790a, for Hematological Malignancies","has_exemption":false,"start_date":"2026-01-16","completion_date":"2030-11-30","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07290738","publication_url":"https://clinicaltrials.gov/study/NCT07290738","title":"TMS for Negative Symptoms in Schizophrenia Spectrum Disorders","has_exemption":false,"start_date":"2026-03-13","completion_date":"2030-11-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07298902","publication_url":"https://clinicaltrials.gov/study/NCT07298902","title":"Non-Invasive Deep Brain Neuromodulation for Smoking Cessation","has_exemption":false,"start_date":"2026-03-15","completion_date":"2030-11-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07559630","publication_url":"https://clinicaltrials.gov/study/NCT07559630","title":"STRATOS: Single-center Randomized Controlled Trial of Rectal Arterial Embolization vs Band Ligation for the Treatment of Internal hemOrrhoidS","has_exemption":false,"start_date":"2026-05-29","completion_date":"2030-11-30","has_results":false,"results_due":false,"sponsor_name":"Jessica K. Stewart, MD","sponsor_slug":"jessica-k-stewart-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07560046","publication_url":"https://clinicaltrials.gov/study/NCT07560046","title":"Combating Related Epidemics in HCV Through Simplified Testing and Treatment. A Cluster Randomized Trial of Point-of-care Hepatitis C Testing and Treatment Among Key Populations","has_exemption":false,"start_date":"2026-08-01","completion_date":"2030-11-30","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05863351","publication_url":"https://clinicaltrials.gov/study/NCT05863351","title":"Phase III Randomized Trial of Stereotactic Ablative Radiotherapy (SAbR) for Oligometastatic Advanced Renal Carcinoma (SOAR)","has_exemption":false,"start_date":"2023-09-07","completion_date":"2030-12-01","has_results":false,"results_due":false,"sponsor_name":"ECOG-ACRIN Cancer Research Group","sponsor_slug":"ecog-acrin-cancer-research-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06569680","publication_url":"https://clinicaltrials.gov/study/NCT06569680","title":"Phase II Trial of Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma (EMZL) (ML44933)","has_exemption":false,"start_date":"2024-11-19","completion_date":"2030-12-01","has_results":false,"results_due":false,"sponsor_name":"Izidore Lossos, MD","sponsor_slug":"izidore-lossos-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06540963","publication_url":"https://clinicaltrials.gov/study/NCT06540963","title":"Phase II Trial of Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma","has_exemption":false,"start_date":"2024-12-06","completion_date":"2030-12-01","has_results":false,"results_due":false,"sponsor_name":"Giselle Sholler","sponsor_slug":"giselle-sholler","status":"ongoing","is_pact":false,"days_late":null}]}